Overview
Takashi Kumagai practices in Hayama, Japan. Mr. Kumagai is rated as a Distinguished expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Schistosomiasis, Distomatosis, Helminthiasis, and Vertebroplasty.
His clinical research consists of co-authoring 102 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Mr. Kumagai isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- DistomatosisMr. Kumagai isAdvanced. Learn about Distomatosis.
- HelminthiasisMr. Kumagai isAdvanced. Learn about Helminthiasis.
- LeukemiaMr. Kumagai isAdvanced. Learn about Leukemia.
- SchistosomiasisMr. Kumagai isAdvanced. Learn about Schistosomiasis.
- Experienced
- Creeping EruptionMr. Kumagai isExperienced. Learn about Creeping Eruption.
- Marginal Zone Lymphoma (MZL)Mr. Kumagai isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- TenosynovitisMr. Kumagai isExperienced. Learn about Tenosynovitis.
- ToxocariasisMr. Kumagai isExperienced. Learn about Toxocariasis.
- VertebroplastyMr. Kumagai isExperienced. Learn about Vertebroplasty.